XML 39 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Mar. 26, 2019
May 24, 2018
Apr. 10, 2018
Jan. 04, 2018
Jun. 08, 2017
Sep. 30, 2018
Apr. 30, 2018
Jun. 30, 2012
Mar. 31, 2019
NIS [Member]                  
Monthly consultation fee       $ 40,000          
CardioSert Ltd [Member]                  
Initial payment     $ 250,000 $ 50,000          
Number of common shares acquired   6,738 6,738           6,738
Number of common shares acquired, value     $ 74,000            
Buy back amount per patent       $ 1.00          
CardioSert Ltd [Member] | Before Reverse Split [Member]                  
Number of common shares acquired   100,000 100,000            
Bonding Agent [Member]                  
Purchase price of Plaintiffs $ 4,200                
Additional expenses respect to interest from the judgement date $ 25,000                
Securities Purchase Agreement [Member]                  
Purchase price of Plaintiffs         $ 3,375        
Loss contingency, damages sought         1,000        
Short-term liability         $ 3,375        
Minimum [Member] | CardioSert Ltd [Member]                  
Investments       $ 2,000,000          
Minimum [Member] | Technician Research And Development Foundation Limited [Member]                  
Royalties payable as percentage of future sales               1.50%  
Maximum [Member] | Technician Research And Development Foundation Limited [Member]                  
Royalties payable as percentage of future sales               3.00%  
Second Phase [Member] | Contract Research Agreements [Member]                  
Contract expected costs           $ 248,100 $ 130,000    
Israeli Innovation Authority [Member] | 2013 Through March 31, 2019 [Member]                  
Total grants obtained                 $ 1,524,000
Israeli Innovation Authority [Member] | 2013 Through March 31, 2019 [Member] | Minimum [Member]                  
Royalties payable as percentage of future sales                 3.00%
Israeli Innovation Authority [Member] | 2013 Through March 31, 2019 [Member] | Maximum [Member]                  
Royalties payable as percentage of future sales                 3.50%